MGTX MeiraGTx Holdings plc - Ordinary Shares
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$10,79
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$6,6252-Wochen-Tief
$15,3552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.02B
P/E (TTM)
15.2
EPS (TTM)
$0.71
Umsatz (TTM)
$398M
Ihre Abzeichen
52W-Spanne
$7–$15
Analystenbewertung
BUY
Kursziel
$28
P/E
15.2
ROE
72.2%
Nettogewinnmarge
19.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
MGTX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$10.79
Marktkapitalisierung (MRQ)
$1.02B
P/E (TTM)
15.2
EPS (TTM)
$0.71
Umsatz (TTM)
$398M
ROE (TTM)
72.2%
Verschuldungsgrad
-4.3
52W-Spanne
$7–$15
MGTX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$81M2019-12-31 → 2025-12-31
EPS$-1.422020-12-31 → 2025-12-31
Freier Cashflow$-50M2018-12-31 → 2025-12-31
Nettogewinnmarge19.9%2019-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | MGTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 15.25-Jahres-Durchschnitt ≈-5.7 | ≈-5.7 | · | · | |
| P/S (TTM) | 2.65-Jahres-Durchschnitt ≈20.4 | ≈20.4 | 8.0 | Unterbewertet | |
| K/B (MRQ) | 4.75-Jahres-Durchschnitt ≈-18.5 | ≈-18.5 | 4.2 | Überbewertet | |
| EV / EBITDA | -9.0 | · | · | · | |
| Kurs / FCF (TTM) | 97.15-Jahres-Durchschnitt ≈-8.4 | ≈-8.4 | · | · | |
| Kurs / Cashflow (TTM) | 74.25-Jahres-Durchschnitt ≈-25.5 | ≈-25.5 | · | · | |
| EV / Revenue (EV / Umsatz) | 10.3 | · | · | · | |
| EV / FCF | -16.7 | · | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 4.75-Jahres-Durchschnitt ≈4.7 | ≈4.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | MGTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 46.3%5-Jahres-Durchschnitt ≈-387.2% | ≈-387.2% | -308.7% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 49.3%5-Jahres-Durchschnitt ≈-354.8% | ≈-354.8% | -308.7% | Spitzenklasse | |
| Pretax Margin (Vorgewinnmarge) | -140.3%5-Jahres-Durchschnitt ≈-402.4% | ≈-402.4% | · | · | |
| Nettogewinnmarge (TTM) | 19.9%5-Jahres-Durchschnitt ≈-402.4% | ≈-402.4% | -214.0% | Spitzenklasse | |
| ROA (TTM) | 26.5%5-Jahres-Durchschnitt ≈-36.8% | ≈-36.8% | -37.2% | Schwach | |
| ROE (TTM) | 72.2%5-Jahres-Durchschnitt ≈1531.6% | ≈1531.6% | -11.7% | Spitzenklasse | |
| ROIC | -562.0%5-Jahres-Durchschnitt ≈-235.6% | ≈-235.6% | -165.3% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | MGTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Debt / Equity (Fremdkapital / Eigenkapital) | -4.3 | · | · | · | |
| Liquiditätsgrad (MRQ) | 3.85-Jahres-Durchschnitt ≈1.9 | ≈1.9 | 11.5 | Geringe Liquidität | |
| Quick Ratio | 0.65-Jahres-Durchschnitt ≈1.6 | ≈1.6 | 10.4 | Geringe Liquidität | |
| Interest Coverage (Zinsdeckungsgrad) | -8.75-Jahres-Durchschnitt ≈-61.8 | ≈-61.8 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | MGTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 144.6%5-Jahres-Durchschnitt ≈70.9% | ≈70.9% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 72.3%5-Jahres-Durchschnitt ≈21.6% | ≈21.6% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 39.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | MGTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.35-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.2 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 43.9 | · | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$207.1K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
77.7%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 13, 2026 | $1.71 | $-0.47 | 465.8% |
| 31. März 2026 | Mai 14, 2026 | $-0.57 | $-0.41 | -39.2% |
| 31. Dezember 2025 | $0.19 | $-0.58 | 132.3% | |
| 30. September 2025 | $-0.62 | $-0.50 | -24.0% | |
| 30. Juni 2025 | $-0.48 | $-0.48 | -0.65% | |
| 31. März 2025 | $-0.51 | $-0.50 | -2.7% | |
| 31. Dezember 2024 | $-0.50 | $-0.57 | 12.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $81M | $33M | $14M | $16M | $38M | $16M | $13M | |
| R&D Expense | $130M | $119M | $104M | $86M | $67M | $34M | $25M | |
| SG&A Expense | $53M | $54M | $47M | $47M | $44M | $44M | $47M | |
| Operating Expenses | $187M | $197M | $151M | $132M | $110M | $78M | $72M | |
| Operating Income | $-106M | $-164M | $-137M | $-116M | $-73M | $-63M | $-58M | |
| Interest Expense | $12M | $13M | $13M | $5M | $288.0K | $139.0K | $48.6K | |
| Interest Income | $2M | $4M | $2M | $777.0K | $212.0K | $1M | $370.6K | |
| Pretax Income | $-114M | $-148M | $-84M | $-130M | $-80M | $-58M | $-55M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-114M | $-148M | $-84M | $-130M | $-80M | $-58M | $-55M | |
| EPS (Basic) | $-1.42 | $-2.12 | $-1.49 | $-2.87 | $-1.80 | $-1.54 | · | |
| EPS (Diluted) | $-1.42 | $-2.12 | $-1.49 | $-2.87 | $-1.80 | $-1.54 | · | |
| Shares (Basic) | 80,430,186 | 69,822,353 | 56,486,525 | 45,177,857 | 44,139,655 | 37,724,189 | · | |
| Shares (Diluted) | 80,430,186 | 69,822,353 | 56,486,525 | 45,177,857 | 44,139,655 | 37,724,189 | · | |
| EBITDA | $-93M | $-151M | $-123M | $-108M | $-65M | $-58M | $-58M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $66M | $104M | $130M | $116M | $138M | $210M | $227M | |
| Receivables | $3M | $707.0K | $10M | $21M | · | · | · | |
| Inventory | · | $385.0K | · | · | · | · | · | |
| Prepaid Expense | $6M | $7M | $6M | $8M | $8M | $7M | $4M | |
| Other Current Assets | $2M | $2M | $1M | $2M | $2M | $5M | $2M | |
| Current Assets | $92M | $124M | $160M | $154M | $183M | $273M | $269M | |
| PP&E (Net) | $105M | $103M | $116M | $109M | $76M | $44M | $24M | |
| PP&E (Gross) | $158M | $145M | $149M | $130M | $90M | $52M | $28M | |
| Accum. Depreciation | $53M | $42M | $33M | $20M | $14M | $8M | $5M | |
| Intangibles | $578.0K | $821.0K | $1M | $1M | $2M | $2M | · | |
| Other Non-current Assets | $1M | $1M | $2M | $1M | $1M | $1M | $195.1K | |
| Total Assets | $244M | $270M | $327M | $318M | $320M | $364M | $324M | |
| Accounts Payable | $10M | $24M | $16M | $17M | $15M | $7M | $4M | |
| Accrued Liabilities | $33M | $27M | $43M | $40M | $28M | $21M | $18M | |
| Short-term Debt | $25M | · | · | · | · | · | · | |
| Current Liabilities | $123M | $61M | $67M | $82M | $68M | $54M | $49M | |
| Capital Leases | $11M | $8M | $13M | $17M | $20M | $20M | $22M | |
| Deferred Tax | · | · | · | $186.0K | $196.0K | $214.0K | $195.1K | |
| Total Liabilities | $250M | $202M | $189M | $200M | $135M | $125M | $133M | |
| Total Debt | $25M | · | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.4K | |
| Paid-in Capital | $808M | $774M | $694M | $582M | $529M | $504M | $396M | |
| Retained Earnings | $-816M | $-702M | $-554M | $-470M | $-341M | $-261M | $-203M | |
| AOCI | $2M | $-4M | $-1M | $6M | $-3M | $-5M | $-2M | |
| Stockholders' Equity | $-6M | $68M | $138M | $118M | $185M | $239M | $191M | |
| Liabilities + Equity | $244M | $270M | $327M | $318M | $320M | $364M | $324M | |
| Shares Outstanding | 81,120,931 | 78,397,380 | 63,601,015 | 48,477,209 | 44,548,925 | 44,189,150 | 36,791,906 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $13M | $14M | $9M | $8M | $4M | $2M | |
| Stock-based Comp | $22M | $25M | $28M | $29M | $21M | $18M | $16M | |
| Deferred Tax | $-21M | $-24M | $-10M | $-26M | $-37M | $-16M | $-10M | |
| Amort. of Intangibles | · | · | · | $200.0K | $300.0K | $20.0K | $0 | |
| Other Non-cash | $54M | $29M | $-53M | $45M | $77M | $-13M | · | |
| Operating Cash Flow | $-46M | $-104M | $-105M | $-73M | $-11M | $-64M | $20M | |
| CapEx | $4M | $5M | $20M | $45M | $46M | $21M | $9M | |
| Investing Cash Flow | $-4M | $23M | $34M | $-45M | $-62M | $-37M | $-9M | |
| Stock Issued | $15M | $59M | $92M | $25M | · | $87M | $155M | |
| Net Stock Activity | $15M | $59M | $92M | · | · | $87M | $155M | |
| Financing Cash Flow | $12M | $55M | $84M | $95M | $2M | $83M | $148M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | $-50M | $-109M | $-126M | $-118M | $-57M | $-85M | $11M | |
| Levered FCF | $-62M | $-123M | · | $-123M | $-57M | $-85M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -130.2% | -493.4% | · | -730.9% | -194.1% | -401.9% | -438.4% | |
| Net Margin | -140.3% | -444.1% | · | -814.2% | -211.0% | -372.6% | -411.9% | |
| Pretax Margin | -140.3% | -444.1% | · | -814.2% | -211.0% | -372.6% | -411.9% | |
| EBITDA Margin | -114.8% | -454.9% | · | -676.1% | -173.3% | -375.1% | -438.4% | |
| ROA | -44.4% | -49.5% | -26.1% | -40.6% | -23.3% | -16.9% | -26.0% | |
| ROE | 8062.2% | -180.7% | -73.0% | -107.8% | -42.6% | -27.8% | -28.4% | |
| ROIC | -562.0% | -242.1% | · | -98.8% | -39.5% | -26.2% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 2.0 | 2.4 | 1.9 | 2.7 | 5.0 | 5.5 | |
| Quick Ratio | 0.6 | 1.7 | 2.1 | 1.4 | 2.0 | 3.9 | 4.6 | |
| Debt / Equity | -4.3 | · | · | · | · | · | · | |
| Interest Coverage | -8.7 | -12.4 | -10.3 | -23.5 | -254.1 | -449.4 | -1198.6 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | · | 0.0 | 0.1 | 0.0 | 0.1 | |
| Receivables Turnover | 43.9 | 6.1 | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.07 | $0.87 | $2.17 | $2.43 | $4.16 | $5.40 | $5.19 | |
| Revenue / Share | $1.01 | $0.48 | · | $0.35 | $0.85 | · | · | |
| Cash Flow / Share | $-0.58 | $-1.50 | $-1.87 | $-1.62 | $-0.24 | · | · | |
| Cash / Share | $0.81 | $1.32 | $2.04 | $2.38 | $3.09 | $4.74 | $6.18 | |
| EPS (TTM) | $-1.42 | $-2.12 | $-1.49 | $-2.87 | $-1.80 | $-1.54 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 144.6% | 137.4% | -11.9% | -57.8% | 142.2% | · | · | |
| Revenue CAGR 3Y | 72.3% | -4.1% | -3.4% | · | · | · | · | |
| Revenue CAGR 5Y | 39.2% | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $81M | $33M | $14M | $16M | $38M | $16M | $13M | |
| Net Income TTM | $-114M | $-148M | $-84M | $-130M | $-80M | $-58M | $-55M | |
| Market Cap | $645M | $477M | $446M | $316M | $1.06B | $669M | $737M | |
| Enterprise Value | $604M | · | · | · | · | · | · | |
| P/E | -5.6 | -2.9 | -4.7 | -2.3 | -13.2 | -9.8 | · | |
| P/S | 7.9 | 14.3 | 31.9 | 19.9 | 28.1 | 43.0 | 55.4 | |
| P/B | -111.3 | 7.0 | 3.2 | 2.7 | 5.7 | 2.8 | 3.9 | |
| P / Tangible Book | · | 7.1 | 3.3 | 2.7 | 5.8 | 2.8 | · | |
| P / Cash Flow | -13.9 | -4.6 | -4.2 | -4.3 | -100.4 | -10.5 | 36.7 | |
| P / FCF | -12.9 | -4.4 | -3.6 | -2.7 | -18.6 | -7.9 | 66.6 | |
| EV / EBITDA | -6.5 | · | · | · | · | · | · | |
| EV / FCF | -12.0 | · | · | · | · | · | · | |
| EV / Revenue | 7.4 | · | · | · | · | · | · | |
| Earnings Yield | -17.9% | -34.8% | -21.2% | -44.0% | -7.6% | -10.2% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321M | $293.0K | $75M | $410.0K | $4M | $2M | $21M | $11M | $282.0K | $697.0K | $2M | $5M | $4M | $3M | · | $5M | |
| R&D Expense | $58M | $32M | $31M | $33M | $33M | $33M | $24M | $26M | $35M | $34M | $34M | $28M | $20M | $22M | $22M | $17M | |
| SG&A Expense | $12M | $9M | $18M | $14M | $12M | $9M | $17M | $13M | $11M | $13M | $12M | $10M | $12M | $13M | $14M | $11M | |
| Operating Expenses | $77M | $41M | $49M | $46M | $48M | $44M | $53M | $51M | $46M | $47M | $46M | $38M | $32M | $35M | $36M | $28M | |
| Operating Income | $244M | $-41M | $26M | $-46M | $-45M | $-42M | $-31M | $-40M | $-46M | $-47M | $-44M | $-33M | $-29M | $-32M | $-41M | $-23M | |
| Interest Expense | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Interest Income | $706.0K | $189.0K | $278.0K | $161.0K | $408.0K | $971.0K | $1M | $1M | $827.0K | $1M | $549.0K | $523.0K | $655.0K | $545.0K | $432.0K | $288.0K | |
| Income Tax | $2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | |
| Net Income | $161M | $-46M | $15M | $-51M | $-39M | $-40M | $-39M | $-39M | $-49M | $-20M | $20M | $-44M | $-30M | $-30M | $-27M | $-37M | |
| EPS (Basic) | $1.76 | $-0.57 | $0.19 | $-0.62 | $-0.48 | $-0.51 | $-0.49 | $-0.55 | $-0.76 | $-0.32 | $0.40 | $-0.74 | $-0.53 | $-0.62 | $-0.58 | $-0.83 | |
| EPS (Diluted) | $1.71 | $-0.57 | $0.19 | $-0.62 | $-0.48 | $-0.51 | $-0.49 | $-0.55 | $-0.76 | $-0.32 | $0.40 | $-0.74 | $-0.53 | $-0.62 | $-0.58 | $-0.83 | |
| Shares (Basic) | 91,418,527 | 81,300,944 | · | 80,947,703 | 80,585,625 | 79,032,341 | · | 71,633,150 | 64,376,396 | 64,065,895 | · | 59,526,642 | 55,349,534 | 48,638,151 | · | 44,687,635 | |
| Shares (Diluted) | 93,805,296 | 81,300,944 | · | 80,947,703 | 80,585,625 | 79,032,341 | · | 71,633,150 | 64,376,396 | 64,065,895 | · | 59,526,642 | 55,349,534 | 48,638,151 | · | 44,687,635 | |
| EBITDA | $244M | $-38M | · | $-43M | $-42M | $-39M | · | $-40M | $-46M | $-43M | · | $-33M | $-29M | $-29M | · | $-23M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $143M | $72M | $66M | $15M | $32M | $67M | $104M | $123M | $100M | $119M | $130M | $63M | $93M | $69M | $116M | $115M | |
| Receivables | · | $3M | $3M | $3M | $2M | $734.0K | $707.0K | $3M | $2M | $11M | $10M | $22M | $33M | · | $21M | · | |
| Inventory | · | · | · | · | $314.0K | $607.0K | $385.0K | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $6M | $7M | $7M | $7M | $7M | $7M | $5M | $5M | $6M | $7M | $8M | $7M | $8M | $10M | |
| Other Current Assets | $27M | $670.0K | $2M | $328.0K | $780.0K | $606.0K | $2M | $713.0K | $660.0K | $932.0K | $1M | $758.0K | $2M | $2M | $2M | $2M | |
| Current Assets | $218M | $96M | $92M | $34M | $47M | $80M | $124M | $139M | $111M | $149M | $160M | $104M | $143M | $121M | $154M | $155M | |
| PP&E (Net) | $100M | $103M | $105M | $108M | $111M | $104M | $103M | $113M | $109M | $111M | $116M | $112M | $114M | $113M | $109M | $94M | |
| PP&E (Gross) | · | · | $158M | · | · | · | $145M | · | · | · | $149M | · | · | · | $130M | · | |
| Accum. Depreciation | · | · | $53M | · | · | · | $42M | · | · | · | $33M | · | · | · | $20M | · | |
| Intangibles | $421.0K | $494.0K | $578.0K | $653.0K | $742.0K | $773.0K | $821.0K | $951.0K | $969.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Total Assets | $396M | $245M | $244M | $189M | $199M | $224M | $270M | $299M | $267M | $309M | $327M | $267M | $310M | $288M | $318M | $301M | |
| Accounts Payable | $12M | $17M | $10M | $22M | $26M | $20M | $24M | $30M | $21M | $21M | $16M | $21M | $28M | $30M | $17M | $22M | |
| Accrued Liabilities | $21M | $25M | $33M | $24M | $15M | $24M | $27M | $19M | $17M | $17M | $43M | $28M | $25M | $31M | $40M | $25M | |
| Short-term Debt | · | $25M | $25M | $74M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $58M | $176M | $123M | $153M | $53M | $52M | $61M | $59M | $47M | $48M | $67M | $64M | $72M | $81M | $82M | $72M | |
| Capital Leases | $10M | $11M | $11M | $12M | $4M | $4M | $8M | $10M | $11M | $12M | $13M | $14M | $16M | $16M | $17M | $17M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $184.0K | $189.0K | $189.0K | $186.0K | $171.0K | |
| Total Liabilities | $181M | $303M | $250M | $230M | $196M | $191M | $202M | $204M | $187M | $188M | $189M | $175M | $187M | $198M | $200M | $179M | |
| Total Debt | · | $25M | · | $74M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $932M | $820M | $808M | $797M | $791M | $780M | $774M | $763M | $707M | $700M | $694M | $659M | $653M | $587M | $582M | $550M | |
| Retained Earnings | $-702M | $-863M | $-816M | $-831M | $-781M | $-742M | $-702M | $-663M | $-623M | $-575M | $-554M | $-574M | $-530M | $-501M | $-470M | $-443M | |
| Treasury Stock | $18M | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $3M | $3M | $2M | $-6M | $-8M | $-5M | $-4M | $-5M | $-4M | $-3M | $-1M | $7M | $1M | $4M | $6M | $15M | |
| Stockholders' Equity | $216M | $-58M | $-6M | $-41M | $3M | $33M | $68M | $96M | $80M | $122M | $138M | $92M | $124M | $90M | $118M | $123M | |
| Liabilities + Equity | $396M | $245M | $244M | $189M | $199M | $224M | $270M | $299M | $267M | $309M | $327M | $267M | $310M | $288M | $318M | $301M | |
| Shares Outstanding | 94,188,118 | 81,446,126 | 81,120,931 | 80,479,684 | 80,446,284 | 79,418,438 | 78,397,380 | 77,695,418 | 64,684,187 | 64,298,691 | 63,601,015 | 59,597,151 | 59,535,314 | 48,477,209 | 48,477,209 | 44,710,678 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Stock-based Comp | $4M | $4M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | |
| Other Non-cash | · | $57M | · | · | · | $-5M | · | · | · | $-27M | · | · | · | $-17M | · | · | |
| Operating Cash Flow | $-39M | $18M | $47M | $-12M | $-44M | $-37M | $-23M | $-25M | $-19M | $-37M | $-15M | $-24M | $-29M | $-37M | $-16M | $-21M | |
| CapEx | $332.0K | $2M | $272.0K | $610.0K | $1M | $2M | $1M | $730.0K | $1M | $2M | $3M | $4M | $5M | $9M | $8M | $10M | |
| Investing Cash Flow | $-24M | $-2M | $-1M | $-547.0K | $-761.0K | $-2M | $-1M | $-1M | $-1M | $27M | $51M | $-4M | $-5M | $-9M | $-8M | $-10M | |
| Stock Issued | $114M | $14M | $5M | $0 | $5M | $4M | $4M | $52M | $2M | $2M | $30M | $0 | · | · | · | · | |
| Stock Repurchased | $0 | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-4M | · | · | · | $4M | · | · | · | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $134M | $-10M | $5M | $-219.0K | $5M | $2M | $4M | $50M | $2M | $-1M | $28M | $-404.0K | $58M | $-1M | $25M | $73M | |
| Free Cash Flow | · | $16M | · | · | · | $-39M | · | · | · | $-38M | · | · | · | $-46M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 76.0% | -13930.7% | · | -11232.0% | -1213.6% | · | · | -367.0% | -16279.8% | -6710.5% | · | -642.0% | -813.1% | -952.6% | · | -473.6% | |
| Net Margin | 50.0% | -15806.5% | · | -12320.2% | -1051.1% | · | · | -360.5% | -17241.1% | -2932.9% | · | -868.1% | -835.6% | -910.7% | · | -774.2% | |
| EBITDA Margin | 76.0% | -12904.1% | · | -10462.4% | -1127.1% | · | · | -367.0% | -16279.8% | -6240.6% | · | -642.0% | -813.1% | -859.9% | · | -473.6% | |
| ROA | 54.0% | -19.8% | · | -20.7% | -16.7% | -15.0% | · | -13.9% | -16.9% | -6.8% | · | -15.6% | -10.5% | -10.5% | · | -12.3% | |
| ROE | 146.9% | 370.1% | · | -183.1% | -93.5% | -51.6% | · | -41.9% | -47.8% | -19.3% | · | -41.3% | -22.3% | -24.1% | · | -24.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 0.5 | · | 0.2 | 0.9 | 1.5 | · | 2.3 | 2.4 | 3.1 | · | 1.6 | 2.0 | 1.5 | · | 2.1 | |
| Quick Ratio | 2.5 | 0.4 | · | 0.1 | 0.6 | 1.3 | · | 2.1 | 2.2 | 2.7 | · | 1.4 | 1.7 | 0.8 | · | 1.6 | |
| Debt / Equity | · | -0.4 | · | -1.8 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | 69.7 | -14.3 | · | -15.0 | -14.8 | -13.7 | · | -11.9 | -14.1 | -14.4 | · | -9.7 | -8.6 | -10.4 | · | -12.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | 0.1 | · | 0.1 | 1.9 | · | · | 0.8 | 0.0 | 0.1 | · | 0.5 | 0.2 | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.29 | $-0.71 | · | $-0.50 | $0.04 | $0.42 | · | $1.23 | $1.24 | $1.89 | · | $1.54 | $2.07 | $1.86 | · | $2.74 | |
| Revenue / Share | $3.43 | $0.00 | · | $0.01 | $0.05 | · | · | $0.15 | $0.00 | $0.01 | · | $0.09 | $0.06 | $0.07 | · | $0.11 | |
| Cash Flow / Share | · | $0.22 | · | · | · | $-0.47 | · | · | · | $-0.57 | · | · | · | $-0.77 | · | · | |
| Cash / Share | $1.52 | $0.88 | · | $0.18 | $0.40 | $0.84 | · | $1.58 | $1.55 | $1.85 | · | $1.06 | $1.56 | $1.42 | · | $2.57 | |
| EPS (TTM) | $0.71 | $-1.48 | · | $-2.10 | $-2.03 | $-2.31 | · | $-1.23 | $-1.42 | $-1.19 | · | $-2.47 | $-2.56 | $-2.79 | · | $-2.50 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $398M | $80M | · | $27M | $38M | $35M | · | $14M | $8M | $11M | · | · | · | · | · | $42M | |
| Net Income TTM | $79M | $-121M | · | $-169M | $-158M | $-167M | · | $-88M | $-93M | $-74M | · | $-132M | $-125M | $-129M | · | $-112M | |
| Market Cap | $1.27B | $705M | · | $662M | $525M | $538M | · | $324M | $272M | $390M | · | $293M | $400M | $251M | · | $376M | |
| Enterprise Value | · | $659M | · | $722M | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 19.0 | -5.9 | · | -3.9 | -3.2 | -2.9 | · | -3.4 | -3.0 | -5.1 | · | -2.0 | -2.6 | -1.9 | · | -3.4 | |
| P/S | 3.2 | 8.8 | · | 24.2 | 13.8 | 15.6 | · | 23.3 | 33.5 | 34.3 | · | · | · | · | · | 8.9 | |
| P/B | 5.9 | -12.1 | · | -16.3 | 177.2 | 16.3 | · | 3.4 | 3.4 | 3.2 | · | 3.2 | 3.2 | 2.8 | · | 3.1 | |
| P / Tangible Book | 5.9 | · | · | · | 236.5 | 16.7 | · | 3.4 | 3.4 | 3.2 | · | 3.2 | 3.3 | 2.8 | · | 3.1 | |
| P / Cash Flow | · | 39.6 | · | · | · | -14.6 | · | · | · | -10.6 | · | · | · | -6.7 | · | · | |
| EV / Revenue | · | 8.3 | · | 26.3 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 5.3% | -17.1% | · | -25.5% | -31.1% | -34.1% | · | -29.5% | -33.7% | -19.6% | · | -50.3% | -38.1% | -54.0% | · | -29.7% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $81M | $33M | $14M | $16M | $38M |
| Betriebsgewinnmarge % | -130.2% | -493.4% | · | -730.9% | -194.1% |
| Nettoergebnis | $-114M | $-148M | $-84M | $-130M | $-80M |
| Verwässerte EPS | $-1.42 | $-2.12 | $-1.49 | $-2.87 | $-1.80 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | -4.3 | · | · | · | · |
| Liquiditätsgrad | 0.7 | 2.0 | 2.4 | 1.9 | 2.7 |
| Quick Ratio | 0.6 | 1.7 | 2.1 | 1.4 | 2.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-50M | $-109M | $-126M | $-118M | $-57M |
Institutionelle Eigentümer (13F) 165 Einreicher · $1.1B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
165
Gehaltener Wert
$1.1B
Neue Positionen
41
Geschlossene Positionen
12
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 41 (+19 vs. Vorquartal) | 12 (-4 vs. Vorquartal) | 79 (+32 vs. Vorquartal) | 22 (-18 vs. Vorquartal) | +11.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Sanofi | $164.791.427 | 12.197.737 | 15,52% | Aktien |
| PERCEPTIVE ADVISORS LLC | $145.727.749 | 10.786.658 | 13,72% | Aktien |
| Rubric Capital Management LP | $122.941.000 | 9.100.000 | 11,58% | Aktien |
| JOHNSON & JOHNSON | $89.720.775 | 6.641.064 | 8,45% | Aktien |
| BlackRock, Inc. | $64.269.475 | 4.757.178 | 6,05% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $59.444.000 | 4.400.000 | 5,60% | Aktien |
| Opaleye Management Inc. | $47.960.500 | 3.550.000 | 4,52% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $40.148.370 | 2.971.752 | 3,78% | Aktien |
| 683 Capital Management, LLC | $31.073.000 | 2.300.000 | 2,93% | Aktien |
| Woodline Partners LP | $20.266.824 | 1.500.135 | 1,91% | Aktien |
| STATE STREET CORP | $18.822.429 | 1.393.222 | 1,77% | Aktien |
| MORGAN STANLEY | $17.734.617 | 1.312.703 | 1,67% | Aktien |
| Knoll Capital Management, LLC | $16.887.500 | 1.250.000 | 1,59% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $14.934.238 | 1.105.421 | 1,41% | Aktien |
| Long Focus Capital Management, LLC | $14.594.853 | 1.080.300 | 1,37% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $13.714.082 | 1.015.106 | 1,29% | Aktien |
| D. E. Shaw & Co., Inc. | $11.522.706 | 852.902 | 1,08% | Aktien |
| HEIGHTS CAPITAL MANAGEMENT, INC | $11.483.500 | 850.000 | 1,08% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $11.471.097 | 849.082 | 1,08% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.775.336 | 723.563 | 0,92% | Aktien |
| CITADEL ADVISORS LLC | $8.788.106 | 650.489 | 0,83% | Aktien |
| Erste Asset Management GmbH | $8.667.648 | 691.200 | 0,82% | Aktien |
| Nuveen, LLC | $8.639.091 | 639.459 | 0,81% | Aktien |
| J. Goldman & Co LP | $8.132.642 | 601.972 | 0,77% | Aktien |
| PFM Health Sciences, LP | $6.150.914 | 455.286 | 0,58% | Aktien |
| NORTHERN TRUST CORP | $5.537.141 | 409.855 | 0,52% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $4.730.851 | 350.174 | 0,45% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.423.390 | 327.416 | 0,42% | Aktien |
| VANGUARD GROUP INC | $3.933.287 | 494.753 | 0,37% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.914.117 | 289.720 | 0,37% | Aktien |
| Point72 Asset Management, L.P. | $2.734.329 | 202.393 | 0,26% | Aktien |
| Ghisallo Capital Management LLC | $2.702.000 | 200.000 | 0,25% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $2.655.837 | 196.583 | 0,25% | Aktien |
| Privium Fund Management B.V. | $2.649.473 | 196.112 | 0,25% | Aktien |
| JPMORGAN CHASE & CO | $2.573.360 | 205.212 | 0,24% | Aktien |
| UBS Group AG | $2.493.594 | 184.574 | 0,23% | Aktien |
| Squarepoint Ops LLC | $2.194.186 | 162.412 | 0,21% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $2.000.358 | 148.065 | 0,19% | Aktien |
| Russell Investments Group, Ltd. | $1.990.413 | 147.329 | 0,19% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.930.890 | 142.923 | 0,18% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.924.283 | 142.434 | 0,18% | Aktien |
| Bank of New York Mellon Corp | $1.869.129 | 138.352 | 0,18% | Aktien |
| BLAIR WILLIAM & CO/IL | $1.695.208 | 125.478 | 0,16% | Aktien |
| Voleon Capital Management LP | $1.591.343 | 117.790 | 0,15% | Aktien |
| Swiss National Bank | $1.505.014 | 111.400 | 0,14% | Aktien |
| BARCLAYS PLC | $1.336.882 | 98.955 | 0,13% | Aktien |
| Invesco Ltd. | $1.277.235 | 94.540 | 0,12% | Aktien |
| ALPS ADVISORS INC | $1.258.943 | 93.186 | 0,12% | Aktien |
| Prosight Management, LP | $1.215.900 | 90.000 | 0,11% | Aktien |
| Aquatic Capital Management LLC | $1.176.235 | 87.064 | 0,11% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd. ×9 Einreichungen | 24. April 2026 | 12,60% | Änderung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 19 Insider · 8 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Alexandria Forbes | PRESIDENT & CEO | 18. August 2026 S | 1.325.695 | 0 | 4 | $-2.285.805 |
| Richard Giroux | CFO & COO | 21. Juli 2026 S | 908.530 | 0 | 3 | $-1.485.760 |
| Katherine Breedis | Chief Financial Officer | 29. Dezember 2018 A | · | 0 | 0 | $0 |
| Stuart Naylor | CHIEF SCI OFCR, OPHTHALMOLOGY | 7. Juli 2026 S | 640.846 | 0 | 3 | $-668.377 |
| Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 25. Juni 2026 A | 57.377 | 0 | 0 | $0 |
| Robert K Zeldin | CHIEF MEDICAL OFFICER | 25. Juni 2026 A | 146.204 | 0 | 0 | $0 |
| Penny Renee Fleck | CHIEF DEVELOPMENT OFFICER | 13. Mai 2026 A | · | 0 | 0 | $0 |
| Bruce Gottlieb | General Counsel | 1. April 2019 A | · | 0 | 0 | $0 |
| Alan Sebulsky | Direktor | 23. September 2026 A | · | 0 | 0 | $0 |
| Debra Yu | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Ellen Hukkelhoven | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Keith R. Harris | Direktor | 11. Juni 2026 A | 200.000 | 0 | 0 | $0 |
| Neil Mendoza | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Nicole Seligman | Direktor | 11. Juni 2026 A | 5.000 | 0 | 0 | $0 |
| Thomas E Shenk | Direktor | 11. Juni 2026 A | 157.476 | 0 | 0 | $0 |
| Martin Indyk | Direktor | 6. Juni 2024 A | 35.000 | 0 | 0 | $0 |
| Joel S Marcus | Direktor | 7. Juni 2022 A | 12.882 | 0 | 0 | $0 |
| Arnold J Levine | Direktor | 7. Juni 2022 A | · | 0 | 0 | $0 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10%-Eigentümer | 15. September 2023 J | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 18 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,18% | 204.089 SH | 11. September 2026 | Täglich |
| ESSC · Strategy Shares | 0,12% | 3.786 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 6.788 SH | 1. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,07% | 535.017 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,04% | 447.107 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 51.041 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 1.527.344 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 57.098 SH | 1. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 28.718 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 345.700 SH | 19. August 2026 | Täglich |
| ISCG · iShares Trust | 0,02% | 12.900 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11.041 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 167.269 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 3.440 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 17.625 SH | 11. September 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.601 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 113.658 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 1.898 SH | 11. September 2026 | Täglich |
MGTX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$23.50
+117,8%
4 30,8%
Starker Kauf
8 61,5%
Kauf
1 7,7%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
8 Analysten · 2026-10-03Mittelwert-Ziel $27.75 +157,2%
← Unter allen Zielen
Aktueller Preis $10.79
Tief$16.00
Mittelwert$27.75
Hoch$50.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | · |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | · |
| BCAX | $953M | -6.7 | · | · | -33.0% | · |
| TRAX | · | · | · | · | · | · |
| VOR | $506M | -0.2 | · | · | 83.4% | · |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | · |
| AKTS | · | · | · | · | · | · |
| ODTX | · | · | · | · | · | · |
| SVRA | $1.23B | -11.4 | · | · | -73.4% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026